NSMCE2 and breast carcinoma: Treatment of breast cancer cells with SE inhibitor JQ1 abrogates the effect of doxorubicin in NSMCE2 upregulation, indicating that NSMCE2 upregulation by doxorubicin is mediated by SEs (Fig. 5E).